Laser - a New Possibility in Fertility Treatment - a Pilot Study

NCT ID: NCT02594852

Last Updated: 2017-10-03

Study Results

Results pending

The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.

Basic Information

Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.

Recruitment Status

TERMINATED

Clinical Phase

NA

Total Enrollment

20 participants

Study Classification

INTERVENTIONAL

Study Start Date

2015-03-31

Study Completion Date

2017-04-30

Brief Summary

Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.

In this study the investigators want to investigate if the pregnancy rate in conjunction with fertility treatment increases with concomitant use of laser therapy.

Detailed Description

Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.

Furthermore the investigators want to examine the participants general mental and physical wellbeing during the experimental period using a VAS-scale.

Conditions

See the medical conditions and disease areas that this research is targeting or investigating.

Infertility Exposure Laser

Study Design

Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.

Allocation Method

RANDOMIZED

Intervention Model

PARALLEL

Primary Study Purpose

TREATMENT

Blinding Strategy

NONE

Study Groups

Review each arm or cohort in the study, along with the interventions and objectives associated with them.

Intervention (+ laser)

\+ laser therapy

Group Type EXPERIMENTAL

+ laser

Intervention Type DEVICE

Use of laser in the treatment

Non-intervention (- laser)

\- laser

Group Type PLACEBO_COMPARATOR

+ laser

Intervention Type DEVICE

Use of laser in the treatment

Interventions

Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.

+ laser

Use of laser in the treatment

Intervention Type DEVICE

Eligibility Criteria

Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.

Inclusion Criteria

1. BMI : 18-32
2. long agonist/short antagonist IVF/intracytoplasmatic sperm injection (ICSI)treatment
3. 1-2 IVF/ICSI treatments without obtaining pregnancy.
4. signed consent

Exclusion Criteria

1. uterine malformations
2. Uterine fibroids/polyps
3. need of an interpreter.
4. D.M, epilepsy, liver-kidney-heart disease
5. endometrial biopsy
6. cancer former cancer disease
7. acupuncture
8. metal in the body
9. suspicious naevi and tatoo´s
Minimum Eligible Age

20 Years

Maximum Eligible Age

40 Years

Eligible Sex

FEMALE

Accepts Healthy Volunteers

Yes

Sponsors

Meet the organizations funding or collaborating on the study and learn about their roles.

Regionshospitalet Viborg, Skive

OTHER

Sponsor Role lead

Responsible Party

Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.

Helle Olesen Elbaek

Clinical Director, M.D

Responsibility Role PRINCIPAL_INVESTIGATOR

Principal Investigators

Learn about the lead researchers overseeing the trial and their institutional affiliations.

Helle Elbaek, M.D

Role: STUDY_DIRECTOR

The Fertility clinic Skive

Locations

Explore where the study is taking place and check the recruitment status at each participating site.

the Fertility clinic, Regional Hospital Skive

Skive, Central Jutland, Denmark

Site Status

Countries

Review the countries where the study has at least one active or historical site.

Denmark

Other Identifiers

Review additional registry numbers or institutional identifiers associated with this trial.

1-10-72-288-14

Identifier Type: -

Identifier Source: org_study_id